share_log

Barrington Research Maintains Outperform on Concentrix, Raises Price Target to $121

Benzinga ·  Jan 25 10:16

Barrington Research analyst Vincent Colicchio maintains Concentrix (NASDAQ:CNXC) with a Outperform and raises the price target from $98 to $121.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment